PedAM
Pediatric Disease Annotations & Medicines
| Disease | back pain |
| Phenotype | C0029456|osteoporosis |
| Sentences | 12 |
| PubMedID- 26180763 | Background: one year, prospective, observational study in an indian subpopulation to assess back pain in patients with severe osteoporosis treated with teriparatide or antiresorptives in a clinical setting. |
| PubMedID- 21800948 | The incidence for adverse events during pa was 3.4%-11% (0.06%-2.4% serious adverse events) and included increased joint pain, fracture, and back pain for those with arthritis, osteoporosis, and low back pain, respectively. |
| PubMedID- 25705348 | The authors should have excluded subjects over 60 years old as this population is prone to osteoporosis, a known cause of back pain. |
| PubMedID- 21494197 | Results: in patients with tm, genetic and acquired risk factors lead to osteoporosis, pathologic fractures of the spine, and back pain. |
| PubMedID- 23293527 | However, chronic back pain possibly associated with spinal osteoporosis and subsequent vertebral fractures persisted. |
| PubMedID- 26171780 | However, fractures and lower back pain attributable to osteoporosis are often key factors affecting the quality of life of older adults. |
| PubMedID- 25012675 | Background and purpose: sacral insufficiency fractures are a common cause of severe low back pain and immobilization in patients with osteoporosis or cancer. |
| PubMedID- 23543381 | Vertebral compression fractures (vfs) are observed in 30-50 % of patients affected by steroid-induced osteoporosis, with consequentially severe back pain and functional limitation. |
| PubMedID- 26327887 | They studied the influence of wbv exercises on the reduction of alendronate on bmd and chronic back pain in women with osteoporosis over a period of 12 months. |
| PubMedID- 25273935 | back pain in patients with severe osteoporosis on teriparatide or antiresorptives: a prospective observational study in a multiethnic population. |
| PubMedID- 23052969 | The ors of frequent low back pain in association with osteoporosis in men and women were 5.77 (95% ci = 4.66-7.15) and 3.49 (95% ci = 2.99-4.07), respectively. |
| PubMedID- 25123562 | Forty-five postmenopausal women diagnosed as having osteoporosis with chronic back pain persisting for more than 3 months, after excluding women with fresh vertebral fractures within the last 6 months, were randomly allocated to a risedronate group (risedronate alone, n = 22) and a combined group (risedronate and elcatonin, n = 23). |
Page: 1